PharmaShots | Incisive News in 3 Shots

Subscribe Now

Cormedix

Cormedix Received the US FDA’s Approval for DefenCath to Reduce Catheter-Related Bloodstream Infections (CRBSI) In Adult Hemodialysis Patients

Cormedix Received the US FDA’s Approval for DefenCath to Reduce Catheter-Related Bloodstream Infections (CRBSI) In Adult Hemodialy...

November 16, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us